menu search

Hotel group accor swings back to profit as travel business rebounds

Europe's biggest hotel group Accor said on Thursday its core earnings swung back to profit in 2021, helped by consecutive business recovery since Apri...

February 24, 2022, 1:38 am

Hotel group accor swings back to profit as travel business rebounds

Europe's biggest hotel group Accor said on Thursday its core earnings swung back to profit in 2021, helped by consecutive business recovery since Apri...

February 24, 2022, 1:38 am

Analysts estimate freshpet (frpt) to report a decline in earnings: what to look out for

Freshpet (Frpt) doesn't possess the right combination of the two key ingredients for a likely earnings ...

February 21, 2022, 4:10 pm

Analysts estimate freshpet (frpt) to report a decline in earnings: what to look out for

Freshpet (Frpt) doesn't possess the right combination of the two key ingredients for a likely earnings ...

February 21, 2022, 4:10 pm

Analysts estimate freshpet (frpt) to report a decline in earnings: what to look out for

Freshpet (Frpt) doesn't possess the right combination of the two key ingredients for a likely earnings ...

February 21, 2022, 4:10 pm

rpt realty (rpt) ceo brian harper on q4 2021 results - earnings call transcript

rpt Realty (rpt) CEO Brian Harper on Q4 2021 Results - E...

February 17, 2022, 3:25 pm

rpt realty (rpt) ceo brian harper on q4 2021 results - earnings call transcript

rpt Realty (rpt) CEO Brian Harper on Q4 2021 Results - E...

February 17, 2022, 3:25 pm

rpt realty (rpt) ceo brian harper on q4 2021 results - earnings call transcript

rpt Realty (rpt) CEO Brian Harper on Q4 2021 Results - E...

February 17, 2022, 3:25 pm

Repare therapeutics to participate in two upcoming virtual investor conferences

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...

February 3, 2022, 7:00 am

Repare therapeutics to participate in two upcoming virtual investor conferences

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...

February 3, 2022, 7:00 am

Repare therapeutics to participate in two upcoming virtual investor conferences

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...

February 3, 2022, 7:00 am

Meritage homes earnings analysis: we see an upside

Meritage Homes recently reported mixed Q4 results with EPS beating the consensus estimates while revenues missed slightly. While abso...

February 2, 2022, 5:31 pm

Meritage homes earnings analysis: we see an upside

Meritage Homes recently reported mixed Q4 results with EPS beating the consensus estimates while revenues missed slightly. While abso...

February 2, 2022, 5:31 pm

Meritage homes earnings analysis: we see an upside

Meritage Homes recently reported mixed Q4 results with EPS beating the consensus estimates while revenues missed slightly. While abso...

February 2, 2022, 5:31 pm

4 reasons why you should add sarepta (srpt) to your portfolio

Sarepta's (Srpt) stock creates a significant opportunity for investors on the back of solid demand for ...

November 26, 2021, 4:02 pm

4 reasons why you should add sarepta (srpt) to your portfolio

Sarepta's (Srpt) stock creates a significant opportunity for investors on the back of solid demand for ...

November 26, 2021, 4:02 pm

4 reasons why you should add sarepta (srpt) to your portfolio

Sarepta's (Srpt) stock creates a significant opportunity for investors on the back of solid demand for ...

November 26, 2021, 4:02 pm

Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne

CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:Srpt), the leade...

October 11, 2021, 9:13 am

Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne

CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:Srpt), the leade...

October 11, 2021, 9:13 am

Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne

CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:Srpt), the leade...

October 11, 2021, 9:13 am


Search within

Pages Search Results: